ONCOLOGY

Cultural and Linguistic Issues in the Assessment and Treatment of Pediatric Cancer Survivors

Dec 10, 2016 by in ONCOLOGY Comments Off on Cultural and Linguistic Issues in the Assessment and Treatment of Pediatric Cancer Survivors

© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_19 19. Cultural and Linguistic Issues in the Assessment and Treatment…

read more

Long-Term Follow-Up Roadmaps by Disease and Treatment

Dec 10, 2016 by in ONCOLOGY Comments Off on Long-Term Follow-Up Roadmaps by Disease and Treatment

Chemotherapy Dose Late effect Baseline screening Anthracycline ≥300 mg/m2 or Cardiomyopathy valvular, pericardial damage, coronary artery disease EKG, ECHO (Doxorubicin >200 mg/m2 + Daunorubicin Chest XRT ≥30 Gy Epirubicin HD…

read more

Second Malignant Neoplasms

Dec 10, 2016 by in ONCOLOGY Comments Off on Second Malignant Neoplasms

Study GWAS vs. candidate gene Study design Replication Sample size Results Therapy-related leukemia-associated with exposure to alkylating agents and topoisomerase II inhibitors Genome-wide association studies Knight et al. 2009 [90]…

read more

Eye, Ear and Oral Health

Dec 10, 2016 by in ONCOLOGY Comments Off on Eye, Ear and Oral Health

Question Response Did the patient have any of the following tumor types: neuroblastoma, brain tumor, germ cell tumor, osteosarcoma, hepatoblastoma? □ Yes □ No Did the patient receive cisplatin chemotherapy?…

read more

Gastrointestinal and Hepatic Systems

Dec 10, 2016 by in ONCOLOGY Comments Off on Gastrointestinal and Hepatic Systems

Cancer treatment risk factor Potential late effect Additional risk factors Recommended evaluation Evidence scorea Mercaptopurine Thioguanine Veno-occlusive disease (VOD) Viral hepatitis Screening 2A Prior VOD Siderosis Mercaptopurine Thioguanine Methotrexate Hepatic…

read more

Pulmonary System

Dec 10, 2016 by in ONCOLOGY Comments Off on Pulmonary System

Fig. 8.1 Mechanisms of pulmonary dysfunction and/or growth by hematopoietic stem cell transplantation (HSCT). BO bronchiolitis obliterans, BOOP bronchiolitis obliterans organizing pneumonia, DAH diffuse alveolar hemorrhage, IPS idiopathic pneumonia syndroma…

read more

Endocrine System

Dec 10, 2016 by in ONCOLOGY Comments Off on Endocrine System

Function Complication Therapy-related risks Relationship to time, dose to gland or organ when applicable Linear Growth GH deficiency Surgery Damage to the pituitary by tumor expansion and/or surgery Radiotherapy to…

read more
Get Clinical Tree app for offline access